GTX (gemcitabine/taxotere/xeloda) with cisplatin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GTX (gemcitabine/taxotere/xeloda) with cisplatin, covering 2019-01-23 to 2019-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer [Phase 2]